UNSPSC 85702316: Supplement sacrum with nonautologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement sacrum with nonautologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0QU13KZ

UNSPSC 85702316 Supplement sacrum with nonautologous tissue substitute, percutaneous approach is a Commodity code that nominally describes a surgical implant procedure, but the recent state and local contract opportunities posted under this code show no alignment with orthopedic or surgical medical devices. The five most recent opportunities—inmate medical and pharmacy services for a county correctional facility, pharmacy benefit management for a county employee health plan, virtual primary and urgent care services for county members, peer support services for behavioral health workers, and fire department medical direction—span healthcare administration, pharmacy benefit management, telemedicine, mental health services, and emergency medical oversight. None of these solicitations involve sacral implants or surgical instrumentation. The code appears to be a data-entry or classification error in the state and local procurement systems, and state and local governments are not currently purchasing sacral implant services through opportunities tagged to this code.

The issuing bodies include county governments (Collier County, Monroe County, and Muscogee County in Georgia), a county health and behavioral health agency (San Mateo County), and a city fire department (Santa Monica). The geographic distribution spans Florida (two counties), Georgia (one county), California (one county), and California municipalities, with no concentration in any single state or region. Because the code carries no substantive activity related to its nominal scope, this category presents no meaningful pursuit opportunity for firms supplying orthopedic implants or surgical devices to state and local healthcare systems.